EUVIMEDObjevte EUVIMED
LeitlinieOpen access · CC BY 4.0

2026 Swiss Society for Infectious Diseases recommendations for Clostridioides difficile infection

Benoit Guery, Werner C Albrich, Silvio D Brugger, Romain Martischang, Virginie Prendki, Giacomo Stroffolini, Sarah Tschudin-Sutter

Swiss Medical Weekly · 2026

DOI: 10.57187/5395 ↗

At a glance

Leitlinie in Swiss Medical Weekly, 2026. Written by Benoit Guery and 6 co-authors. Institution: Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Major MEDLINE topics: Clostridium Infections, Clostridioides difficile, Anti-Bacterial Agents, Practice Guidelines as Topic. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The most recent Swiss Society for Infectious Diseases recommendations for Clostridioides difficile infection (CDI) in Switzerland were based on the 2018 American guidelines. Since then, a large number of new studies have been published, and updated international guidelines – both European and American – have introduced substantial innovations in CDI diagnosis and treatment. This document represents a consensus statement developed by a group of experts appointed by the Swiss Society for Infectious Diseases. The objective of these national guidelines is to provide a comprehensive, evidence-based and context-specific framework for the diagnosis, treatment, prevention and follow-up of CDI across all stages of disease. By synthesising the latest clinical evidence, recent international guideline updates, and national organisational and regulatory considerations, these guidelines aim to harmonise clinical practice, promote high-quality and equitable patient care and support clinicians in making informed, patient-centred decisions within the Swiss healthcare system. These guidelines are endorsed by the Swiss Society for Infectious Diseases.

Subjects

MeSH terms (MEDLINE)

Clostridium InfectionsClostridioides difficileAnti-Bacterial AgentsPractice Guidelines as TopicHumansSwitzerlandSocieties, Medical

Substances

Anti-Bacterial Agents

Authors and institutions

  • Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Division of Infectious Diseases, Infection Prevention and Travel Medicine, HOCH Health Ostschweiz, St Gallen Cantonal Hospital, St Gallen, Switzerland.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Department of internal medicine, rehabilitation and geriatrics, Geneva University Hospitals, Geneva, Switzerland.
  • Division of Infectious Diseases, University Hospital Basel, Basel, Switzerland and Department of Clinical Research, University Hospital Basel, and University of Basel, Basel, Switzerland.

Cite

APA

Guery, B., Albrich, W. C., Brugger, S. D., Martischang, R., Prendki, V., Stroffolini, G., & Tschudin-Sutter, S. (2026). 2026 Swiss Society for Infectious Diseases recommendations for Clostridioides difficile infection. Swiss Medical Weekly. https://doi.org/10.57187/5395

Vancouver

Guery B, Albrich WC, Brugger SD, Martischang R, Prendki V, Stroffolini G, et al. 2026 Swiss Society for Infectious Diseases recommendations for Clostridioides difficile infection. Swiss Medical Weekly. 2026. doi:10.57187/5395

BibTeX
@article{Guery2026,
  author = {Guery, Benoit and Albrich, Werner C and Brugger, Silvio D and Martischang, Romain and Prendki, Virginie and Stroffolini, Giacomo and Tschudin-Sutter, Sarah},
  title = {2026 Swiss Society for Infectious Diseases recommendations for Clostridioides difficile infection},
  journal = {Swiss Medical Weekly},
  year = {2026},
  doi = {10.57187/5395}
}
Start for free →